Prostate cancer is predominantly driven by the androgen receptor (AR). The AR is composed of three domains: the ligand-binding domain (LBD) which binds to androgen hormones, the DNA-binding domain which binds to DNA in cells, and the N-terminal domain (NTD) which is necessary for AR gene transcription.